McKesson Corp (NYSE:MCK)
CAPS Rating:
Providing supply, information and care management products and services designed to reduce costs and improve quality across the healthcare industry.
Providing supply, information and care management products and services designed to reduce costs and improve quality across the healthcare industry.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
Three things are driving McKesson: rapid development of new drugs; demographics; and Medicare Part D. ROIC is high, and the company is selling for only half its estimated fair value based on discounted free cash flow. Their transition to a fee-for-service business model, which hurt the distribitors last year, appears to have been very successful in boosting margins and ROIC, so the reason for the drop in price seems to be behind them.